Letter: body surface area and body muscle parameters may influence adalimumab trough levels.
2nd Department of Medicine, Semmelweis University, Budapest, Hungary.
Á A
ÁA
Csontos
A
A
Molnár
P
P
Miheller
D000893:Anti-Inflammatory Agents / Q000493:pharmacokinetics*; D061067:Antibodies, Monoclonal, Humanized / Q000493:pharmacokinetics*; D003424:Crohn Disease / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male
D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized